$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Oligo-2′-fluoronucleotide N3′->P5′phosphoramidates 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07H-021/00
  • C07H-021/02
  • C07H-021/04
출원번호 US-0603566 (1996-02-21)
발명자 / 주소
  • Gryaznov Sergei (San Mateo CA) Schultz Ronald G. (Fremont CA)
출원인 / 주소
  • Lynx Therapeutics, Inc. (Hayward CA 02)
인용정보 피인용 횟수 : 55  인용 특허 : 1

초록

A new class of oligonucleotide N3′→P5′phosphoramidates having 2′fluoro substituents are provided that have superior acid stability. The invention includes oligo-2′-fluoronucleotide N3′→P5′phosphoramidates, methods of synthesis, and duplexes and triplexes formed with DNA and RNA. Compounds of the inv

대표청구항

A polynucleotide comprising an oligo-2′-fluoronucleoside N3′→P5′phosphoramidate segment defined by the formula: [Figure] wherein B is a purine or pyrimidine, n is an integer greater than 1, and R4 is hydrogen or a phosphate protecting group.

이 특허에 인용된 특허 (1)

  1. Letsinger Robert L. (Wilmette IL) Gryaznov Sergei M. (San Mateo CA), Oligodeoxyribonucleotides including 3′-aminonucleoside-phosphoramidate linkages and terminal 3′-amino groups.

이 특허를 인용한 특허 (55)

  1. Gryaznov,Sergei; Schultz,Ronald G., 2'-arabino-fluorooligonucleotide N3'→P5' phosphoramidates: their synthesis and use.
  2. Prakash, Thazha P.; Baker, Brenda F.; Eldrup, Anne B.; Manoharan, Muthiah; Bhat, Balkrishen; Griffey, Richard; Swayze, Eric E.; Crooke, Stanley T., 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations.
  3. Gryaznov, Sergei; Schultz, Ronald G., 2′-arabino-fluorooligonucleotide N3′-P5′ phosphoramidates: their synthesis and use.
  4. Gryaznov, Sergei M.; Schultz, Ronald G., 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use.
  5. Gryaznov, Sergei M.; Schultz, Ronald G., 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use.
  6. Gryaznov, Sergei; Schultz, Ronald G., 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use.
  7. Schinazi, Raymond F.; Liotta, Dennis C.; Chu, Chung K.; McAtee, J. Jeffrey; Shi, Junxing; Choi, Yongseok; Lee, Kyeong; Hong, Joon H., 2′-fluoronucleosides.
  8. Roderic M. K. Dale, Arrays with modified oligonucleotide and polynucleotide compositions.
  9. Imanishi, Takeshi; Obika, Satoshi, Bicyclonucleoside analogues.
  10. Gryaznov, Sergei M.; Zielinska, Daria; Pruzan, Ronald A.; Lindquist, Jeffrey N., C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders.
  11. Gryaznov, Sergei M.; Zielinska, Daria; Pruzan, Ronald A.; Lindquist, Jeffrey N., C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders.
  12. Crooke, Stanley T., Chimeric oligomeric compounds and their use in gene modulation.
  13. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2′-modified nucleosides for use in gene modulation.
  14. Bennett, C. Frank; McKay, Robert; Monia, Brett P.; Baker, Brenda F.; Sioufi, Namir, Conjugates for use in hepatocyte free uptake assays.
  15. Baker, Brenda F.; Kraynack, Bryan A., Double stranded constructs comprising one or more short strands hybridized to a longer strand.
  16. Woolf, Tod M.; Kamens, Joanne; Khvorova, Anastasia; Salomon, William, Inhibition of MAP4K4 through RNAI.
  17. Kamens, Joanne; Khvorova, Anastasia, Inhibition of PCSK9 through RNAI.
  18. Kamens, Joanne; Khvorova, Anastasia, Inhibition of PCSK9 through RNAi.
  19. Karl Tryggvason SE; Olavi Lukkarinen FI; Pirkko Heikkila SE; Teija Parpala FI, Method for viral vector delivery.
  20. Peters, Marco; Scott, Roderick Euan Milne; Tully, Timothy P., Methods of enhancing long term memory formation by inhibition of Gpr12.
  21. Pavco, Pamela A.; Kamens, Joanne; Woolf, Tod M.; Salomon, William; Khvorova, Anastasia, Modified RNAi polynucleotides and uses thereof.
  22. Gryaznov, Sergei; Pongracz, Krisztina, Modified oligonucleotides for telomerase inhibition.
  23. Gryaznov, Sergei; Pongracz, Krisztina, Modified oligonucleotides for telomerase inhibition.
  24. Gryaznov, Sergei; Pongracz, Krisztina, Modified oligonucleotides for telomerase inhibition.
  25. Gryaznov, Sergei; Pongracz, Krisztina, Modified oligonucleotides for telomerase inhibition.
  26. Gryaznov, Sergei; Pongracz, Krisztina, Modified oligonucleotides for telomerase inhibition.
  27. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Miller, Michelle; Bulock, Karen G., Neutral nanotransporters.
  28. Krull, Ulrich J.; Piunno, Paul A.; Hudson, Robert H. E.; Damha, Masad; Uddin, Andre H., Nucleic acid biosensor diagnostics.
  29. Gryaznov, Sergei; Pongracz, Krisztina; Matray, Tracy, Oligonucleotide N3′→P5′ Thiophosphoramidates: their synthesis and use.
  30. Gryaznov, Sergei; Pongracz, Krisztina; Matray, Tracy, Oligonucleotide N3'→P5' thiophosphoramidates: their synthesis and administration to treat neoplasms.
  31. Ramiya, Premchandran H., Oligonucleotide compositions and methods of making the same.
  32. Khvorova, Anastasia; Aronin, Neil; Alterman, Julia, Oligonucleotide compounds for targeting huntingtin mRNA.
  33. Khvorova, Anastasia; Moore, Melissa; Turanov, Anton A.; Karumanchi, Ananth, Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders.
  34. Crooke, Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  35. Tryggvason, Karl; Lukkarinen, Olavi; Heikkila , Pirkko; Parpala, Teija, Perfusion apparatus and methods for pharmaceutical delivery.
  36. Samarsky, Dmitry; Woolf, Tod M., Phagocytic cell delivery of RNAI.
  37. Bhat, Balkrishen; Swayze, Eric E.; Prakash, Thazha P.; Allerson, Charles; Dande, Prasad; Griffey, Richard H., Positionally modified siRNA constructs.
  38. Gryaznov, Sergei; Pongracz, Krisztina, RNA amidates and thioamidates for RNAi.
  39. Gryaznov, Sergei; Pongracz, Krisztina, RNA amidates and thioamidates for RNAi.
  40. Woolf, Tod M.; Kamens, Joanne; Salomon, William; Khvorova, Anastasia, RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality.
  41. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Libertine, Lyn; Cardia, James; Bulock, Karen G., RNA interference in dermal and fibrotic indications.
  42. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Libertine, Lyn; Cardia, James; Bulock, Karen G., RNA interference in dermal and fibrotic indications.
  43. Libertine, Lyn; Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James; Pavco, Pamela A., RNA interference in ocular indications.
  44. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  45. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  46. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  47. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  48. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  49. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  50. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  51. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  52. Gryaznov, Sergei M.; Pongracz, Krisztina; Zielinska, Daria, Synthesis of protected 3′-amino nucleoside monomers.
  53. Gryaznov, Sergei M.; Pongracz, Krisztina; Zielinska, Daria, Synthesis of protected 3′-amino nucleoside monomers.
  54. Gryaznov, Sergei M.; Pongracz, Krisztina; Zielinska, Daria, Synthesis of protected 3′-amino nucleoside monomers.
  55. Gryaznov,Sergei; Pongracz,Krisztina; Matray,Tracy, Treating cancer using an oligonucleotide N3'->N5' thiophosphoramidate.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로